Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform-Analysis of Production and Immunogenicity.
Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study.
Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection.
Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2.
Selective loss of CD107a TIGIT+ memory HIV-1-specific CD8+ T cells in PLWH over a decade of ART.
Animal models to study the neurological manifestations of the post-COVID-19 condition.
Phenotypic characterization of single CD4+ T cells harboring genetically intact and inducible HIV genomes.
Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate.
Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis.
β-Cyclodextrins as affordable antivirals to treat coronavirus infection.